Inventiva Strengthens Leadership Team Ahead of Key MASH Drug Milestones

By Daniella Parra Inventiva said Dr. Jason Campagna has been named President of R&D and Chief Medical Officer as Inventiva advances lanifibranor, its lead candidate for MASH, with topline Phase 3 results from the NATiV3 trial expected in the second...